Gilead Sciences Inc (GILD)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 144.11B
P/E Ratio
23.04
Revenue (TTM)
$ 28.86B
Volume
0
52W High
$ 121.83
52W Low
$ 74.03
Dividend Yield
2.63%
Beta
0.35
Technicals
50-Day MA
112.4622
200-Day MA
103.8593
52 Week High
121.83
52 Week Low
74.0324
About GILD
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
Employees
17600
Headquarters
Foster City, CA
CEO
Mr. Daniel P. O'Day
Latest News
How Does Gilead's Valuation Stack Up After CVS Excludes New HIV Shot from Coverage? - simplywall.st
9 hours ago • Google News
GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo - Zacks Investment Research
Yesterday • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
22.15
Percentile: 30.98
Environmental Risk Score
0.53
Percentile: 2
Social Risk Score
12.97
Percentile: 2
Governance Risk Score
7.65
Percentile: 2
Controversy Level
ESG data provided by Sustainalytics, Inc.
GILD
Category Average
2Moderate Controversy Level
NoneSevere